These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. High-throughput screening in academia: the Harvard experience. Stein RL. J Biomol Screen; 2003 Dec 01; 8(6):615-9. PubMed ID: 14711386 [Abstract] [Full Text] [Related]
16. High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discovery. Mondal MS, Gabriels J, McGinnis C, Magnifico M, Marsilje TH, Urban L, Collis A, Bojanic D, Biller SA, Frieauff W, Martus HJ, Suter W, Bentley P. Toxicol Sci; 2010 Nov 01; 118(1):71-85. PubMed ID: 20631060 [Abstract] [Full Text] [Related]
17. Assay development and screening of human DGAT1 inhibitors with an LC/MS-based assay: application of mass spectrometry for large-scale primary screening. Zhang JH, Roddy TP, Ho PI, Horvath CR, Vickers C, Stout S, Hubbard B, Wang YK, Hill WA, Bojanic D. J Biomol Screen; 2010 Jul 01; 15(6):695-702. PubMed ID: 20484097 [Abstract] [Full Text] [Related]
18. Rethinking molecular similarity: comparing compounds on the basis of biological activity. Petrone PM, Simms B, Nigsch F, Lounkine E, Kutchukian P, Cornett A, Deng Z, Davies JW, Jenkins JL, Glick M. ACS Chem Biol; 2012 Aug 17; 7(8):1399-409. PubMed ID: 22594495 [Abstract] [Full Text] [Related]
19. Affinity-based screening techniques for enhancing lead discovery. Comess KM, Schurdak ME. Curr Opin Drug Discov Devel; 2004 Jul 17; 7(4):411-6. PubMed ID: 15338950 [Abstract] [Full Text] [Related]